Pages that link to "Q53962416"
Jump to navigation
Jump to search
The following pages link to Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study. (Q53962416):
Displaying 17 items.
- Citalopram in the treatment of depression and other potential uses in psychiatry (Q33677537) (← links)
- Pharmacotherapy in children and adolescents with obsessive-compulsive disorder. (Q33708237) (← links)
- Citalopram--a review of pharmacological and clinical effects (Q33948515) (← links)
- Pharmacotherapy for obsessive-compulsive disorder (Q34032780) (← links)
- Therapeutic approaches to the treatment of refractory obsessive-compulsive disorder (Q34108465) (← links)
- Management of anxiety disorders: the added challenge of comorbidity (Q34218830) (← links)
- Citalopram: a comprehensive review (Q34240991) (← links)
- Anxiety and Depression: Optimizing Treatments (Q34304950) (← links)
- Citalopram controls phobic symptoms in patients with panic disorder: randomized controlled trial (Q34464194) (← links)
- Serotonergic drugs in the treatment of depressive and anxiety disorders (Q34982492) (← links)
- Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review (Q35054424) (← links)
- Parasomnias and antidepressant therapy: a review of the literature (Q35607291) (← links)
- Antidepressants and sleep: a qualitative review of the literature (Q36126504) (← links)
- Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder (Q36326268) (← links)
- Citalopram concentrations and response in obsessive-compulsive disorder. Preliminary results (Q42624938) (← links)
- Citalopram for treatment-resistant obsessive-compulsive disorder. (Q53921638) (← links)
- [Obsessive-compulsive disorder, frontostriatal system and the effect of the serotonergic system] (Q73620859) (← links)